Zoladex

ZOLADEX International Product Monograph



Monographs



  •    ZOLADEX the product (389kb)   View .pdf format

    In this section you will find:
    • Summary
    • What is ‘ZOLADEX’?
    • What is LHRH?
    • How does ‘ZOLADEX’ work?
    • How is ‘ZOLADEX’ formulated?
    • Presentation – a) ‘ZOLADEX’; b) ‘ZOLADEX SafeSystem’
    • Administration – a) ‘ZOLADEX’; b) ‘ZOLADEX’ SafeSystem
    • Dosage and frequency
    • Pharmacokinetics
    • Pharmacology – a) ‘ZOLADEX’ 3.6mg; b) ‘ZOLADEX’ 10.8mg
    • References


  •    ZOLADEX as adjuvant therapy (130kb)   View .pdf format

    In this section you will find:
    • Summary
    • Adjuvant therapy following radiotherapy
    • Adjuvant therapy following radical prostatectomy
    • Cost-effectiveness of ‘ZOLADEX’ adjuvant therapy following radiotherapy
    • References



  •    ZOLADEX monotherapy in advanced prostate cancer (143kb)   View .pdf format

    In this section you will find:
    • Summary
    • Comparison of ‘ZOLADEX’ with orchidectomy
    • Comparison of ‘ZOLADEX’ with oestrogens
    • Comparison of ‘ZOLADEX’ with cyproterone acetate
    • Patient preference
    • Quality of life
    • References







Search

Information for

This is an AstraZeneca International website for healthcare professionals. The site is not intended for the following audiences who should use the links below:

Please note

Not all indications / uses of ZOLADEX are registered in all countries. Please consult local prescribing information.

Quick links

Features

Site services